Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of ZX-7101A in liver insufficiency
NCT05711797Phase 1Completed
- Sponsor
- Zenshine Pharmaceuticals Co., Ltd.
- Start
- Apr 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Seloxavir marboxil in influenza (2 arms), sponsored by Zenshine Pharmaceuticals Co., Ltd. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Apr 2023; status: completed.
02
Drugs
Seloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05711797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05711797.